Achievement of European guideline-recommended lipid levels post-percutaneous coronary intervention: A population-level observational cohort study

Harris, Daniel; Lacey, Arron S.; Akbari, Ashley; Torabi, Fatemeh; Smith, Dave; Jenkins, Geraint; Obaid, Daniel; Chase, Alex; Gravenor, Michael; Halcox, Julian; Torabi, Fatemeh

doi:10.1177/2047487320914115

Journal article 953 views 119 downloads

Achievement of European guideline-recommended lipid levels post-percutaneous coronary intervention: A population-level observational cohort study

Daniel Harris, Arron S. Lacey

, Ashley Akbari

, Fatemeh Torabi, Dave Smith, Geraint Jenkins, Daniel Obaid

, Alex Chase, Michael Gravenor

, Julian Halcox

, Fatemeh Torabi

European Journal of Preventive Cardiology, Start page: 204748732091411

Swansea University Authors: Daniel Harris, Arron S. Lacey , Ashley Akbari , Daniel Obaid , Michael Gravenor , Julian Halcox , Fatemeh Torabi

PDF | Version of Record

Released under the terms of a Creative Commons Attribution-NonCommercial 4.0 License (CC-BY-NC).
Download (423.54KB)

Check full text

DOI (Published version): 10.1177/2047487320914115

Abstract

European Society of Cardiology/European Atherosclerosis Society 2019 guidelines recommend more aggressive lipid targets in high- and very high-risk patients and the addition of adjuvant treatments to statins in uncontrolled patients. We aimed to assess (a) achievement of prior and new European Socie...

Full description

Published in:	European Journal of Preventive Cardiology
ISSN:	2047-4873 2047-4881
Published:	SAGE Publications 2020
Online Access:	Check full text
URI:	https://cronfa.swan.ac.uk/Record/cronfa53918

first_indexed	2020-04-16T19:42:18Z
last_indexed	2024-11-14T12:05:42Z
id	cronfa53918
recordtype	SURis
fullrecord	<?xml version="1.0"?><rfc1807><datestamp>2024-10-29T14:12:19.0451116</datestamp><bib-version>v2</bib-version><id>53918</id><entry>2020-02-28</entry><title>Achievement of European guideline-recommended lipid levels post-percutaneous coronary intervention: A population-level observational cohort study</title><swanseaauthors><author><sid>e60c9c73b645f0e8033ae26fa8e634b8</sid><firstname>Daniel</firstname><surname>Harris</surname><name>Daniel Harris</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>7af5c8bdd1197f85720e4f3d65e803eb</sid><ORCID>0000-0001-7983-8073</ORCID><firstname>Arron S.</firstname><surname>Lacey</surname><name>Arron S. Lacey</name><active>true</active><ethesisStudent>true</ethesisStudent></author><author><sid>aa1b025ec0243f708bb5eb0a93d6fb52</sid><ORCID>0000-0003-0814-0801</ORCID><firstname>Ashley</firstname><surname>Akbari</surname><name>Ashley Akbari</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>1cb4b49224d4f3f2b546ed0f39e13ea8</sid><ORCID>0000-0002-3891-1403</ORCID><firstname>Daniel</firstname><surname>Obaid</surname><name>Daniel Obaid</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>70a544476ce62ba78502ce463c2500d6</sid><ORCID>0000-0003-0710-0947</ORCID><firstname>Michael</firstname><surname>Gravenor</surname><name>Michael Gravenor</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>3676f695eeda169d0f8c618adf27c04b</sid><ORCID>0000-0001-6926-2947</ORCID><firstname>Julian</firstname><surname>Halcox</surname><name>Julian Halcox</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>f569591e1bfb0e405b8091f99fec45d3</sid><ORCID>0000-0002-5853-4625</ORCID><firstname>Fatemeh</firstname><surname>Torabi</surname><name>Fatemeh Torabi</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2020-02-28</date><deptcode>MEDS</deptcode><abstract>European Society of Cardiology/European Atherosclerosis Society 2019 guidelines recommend more aggressive lipid targets in high- and very high-risk patients and the addition of adjuvant treatments to statins in uncontrolled patients. We aimed to assess (a) achievement of prior and new European Society of Cardiology/European Atherosclerosis Society lipid targets and (b) lipid-lowering therapy prescribing in a nationwide cohort of very high-risk patients.</abstract><type>Journal Article</type><journal>European Journal of Preventive Cardiology</journal><volume/><journalNumber/><paginationStart>204748732091411</paginationStart><paginationEnd/><publisher>SAGE Publications</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>2047-4873</issnPrint><issnElectronic>2047-4881</issnElectronic><keywords>Lipids, cholesterol, statins, pharmacoepidemiology, percutaneous coronary intervention, secondary prevention</keywords><publishedDay>31</publishedDay><publishedMonth>3</publishedMonth><publishedYear>2020</publishedYear><publishedDate>2020-03-31</publishedDate><doi>10.1177/2047487320914115</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm>Other</apcterm><funders>This study was funded by Swansea Bay University Health Board research and development department.</funders><projectreference/><lastEdited>2024-10-29T14:12:19.0451116</lastEdited><Created>2020-02-28T00:00:00.0000000</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Daniel</firstname><surname>Harris</surname><order>1</order></author><author><firstname>Arron S.</firstname><surname>Lacey</surname><orcid>0000-0001-7983-8073</orcid><order>2</order></author><author><firstname>Ashley</firstname><surname>Akbari</surname><orcid>0000-0003-0814-0801</orcid><order>3</order></author><author><firstname>Fatemeh</firstname><surname>Torabi</surname><order>4</order></author><author><firstname>Dave</firstname><surname>Smith</surname><order>5</order></author><author><firstname>Geraint</firstname><surname>Jenkins</surname><order>6</order></author><author><firstname>Daniel</firstname><surname>Obaid</surname><orcid>0000-0002-3891-1403</orcid><order>7</order></author><author><firstname>Alex</firstname><surname>Chase</surname><order>8</order></author><author><firstname>Michael</firstname><surname>Gravenor</surname><orcid>0000-0003-0710-0947</orcid><order>9</order></author><author><firstname>Julian</firstname><surname>Halcox</surname><orcid>0000-0001-6926-2947</orcid><order>10</order></author><author><firstname>Fatemeh</firstname><surname>Torabi</surname><orcid>0000-0002-5853-4625</orcid><order>11</order></author></authors><documents><document><filename>53918__17172__972ec0d2232441939d22f6799e2d3d3c.pdf</filename><originalFilename>53918.pdf</originalFilename><uploaded>2020-05-01T14:44:46.1329827</uploaded><type>Output</type><contentLength>433704</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>Released under the terms of a Creative Commons Attribution-NonCommercial 4.0 License (CC-BY-NC).</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>https://creativecommons.org/licenses/by-nc/4.0/</licence></document></documents><OutputDurs/></rfc1807>
spelling	2024-10-29T14:12:19.0451116 v2 53918 2020-02-28 Achievement of European guideline-recommended lipid levels post-percutaneous coronary intervention: A population-level observational cohort study e60c9c73b645f0e8033ae26fa8e634b8 Daniel Harris Daniel Harris true false 7af5c8bdd1197f85720e4f3d65e803eb 0000-0001-7983-8073 Arron S. Lacey Arron S. Lacey true true aa1b025ec0243f708bb5eb0a93d6fb52 0000-0003-0814-0801 Ashley Akbari Ashley Akbari true false 1cb4b49224d4f3f2b546ed0f39e13ea8 0000-0002-3891-1403 Daniel Obaid Daniel Obaid true false 70a544476ce62ba78502ce463c2500d6 0000-0003-0710-0947 Michael Gravenor Michael Gravenor true false 3676f695eeda169d0f8c618adf27c04b 0000-0001-6926-2947 Julian Halcox Julian Halcox true false f569591e1bfb0e405b8091f99fec45d3 0000-0002-5853-4625 Fatemeh Torabi Fatemeh Torabi true false 2020-02-28 MEDS European Society of Cardiology/European Atherosclerosis Society 2019 guidelines recommend more aggressive lipid targets in high- and very high-risk patients and the addition of adjuvant treatments to statins in uncontrolled patients. We aimed to assess (a) achievement of prior and new European Society of Cardiology/European Atherosclerosis Society lipid targets and (b) lipid-lowering therapy prescribing in a nationwide cohort of very high-risk patients. Journal Article European Journal of Preventive Cardiology 204748732091411 SAGE Publications 2047-4873 2047-4881 Lipids, cholesterol, statins, pharmacoepidemiology, percutaneous coronary intervention, secondary prevention 31 3 2020 2020-03-31 10.1177/2047487320914115 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University Other This study was funded by Swansea Bay University Health Board research and development department. 2024-10-29T14:12:19.0451116 2020-02-28T00:00:00.0000000 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Daniel Harris 1 Arron S. Lacey 0000-0001-7983-8073 2 Ashley Akbari 0000-0003-0814-0801 3 Fatemeh Torabi 4 Dave Smith 5 Geraint Jenkins 6 Daniel Obaid 0000-0002-3891-1403 7 Alex Chase 8 Michael Gravenor 0000-0003-0710-0947 9 Julian Halcox 0000-0001-6926-2947 10 Fatemeh Torabi 0000-0002-5853-4625 11 53918__17172__972ec0d2232441939d22f6799e2d3d3c.pdf 53918.pdf 2020-05-01T14:44:46.1329827 Output 433704 application/pdf Version of Record true Released under the terms of a Creative Commons Attribution-NonCommercial 4.0 License (CC-BY-NC). true eng https://creativecommons.org/licenses/by-nc/4.0/
title	Achievement of European guideline-recommended lipid levels post-percutaneous coronary intervention: A population-level observational cohort study
spellingShingle	Achievement of European guideline-recommended lipid levels post-percutaneous coronary intervention: A population-level observational cohort study Daniel Harris Arron S. Lacey Ashley Akbari Daniel Obaid Michael Gravenor Julian Halcox Fatemeh Torabi
title_short	Achievement of European guideline-recommended lipid levels post-percutaneous coronary intervention: A population-level observational cohort study
title_full	Achievement of European guideline-recommended lipid levels post-percutaneous coronary intervention: A population-level observational cohort study
title_fullStr	Achievement of European guideline-recommended lipid levels post-percutaneous coronary intervention: A population-level observational cohort study
title_full_unstemmed	Achievement of European guideline-recommended lipid levels post-percutaneous coronary intervention: A population-level observational cohort study
title_sort	Achievement of European guideline-recommended lipid levels post-percutaneous coronary intervention: A population-level observational cohort study
author_id_str_mv	e60c9c73b645f0e8033ae26fa8e634b8 7af5c8bdd1197f85720e4f3d65e803eb aa1b025ec0243f708bb5eb0a93d6fb52 1cb4b49224d4f3f2b546ed0f39e13ea8 70a544476ce62ba78502ce463c2500d6 3676f695eeda169d0f8c618adf27c04b f569591e1bfb0e405b8091f99fec45d3
author_id_fullname_str_mv	e60c9c73b645f0e8033ae26fa8e634b8_*_Daniel Harris 7af5c8bdd1197f85720e4f3d65e803eb__Arron S. Lacey aa1b025ec0243f708bb5eb0a93d6fb52__Ashley Akbari 1cb4b49224d4f3f2b546ed0f39e13ea8__Daniel Obaid 70a544476ce62ba78502ce463c2500d6__Michael Gravenor 3676f695eeda169d0f8c618adf27c04b__Julian Halcox f569591e1bfb0e405b8091f99fec45d3_**_Fatemeh Torabi
author	Daniel Harris Arron S. Lacey Ashley Akbari Daniel Obaid Michael Gravenor Julian Halcox Fatemeh Torabi
author2	Daniel Harris Arron S. Lacey Ashley Akbari Fatemeh Torabi Dave Smith Geraint Jenkins Daniel Obaid Alex Chase Michael Gravenor Julian Halcox Fatemeh Torabi
format	Journal article
container_title	European Journal of Preventive Cardiology
container_start_page	204748732091411
publishDate	2020
institution	Swansea University
issn	2047-4873 2047-4881
doi_str_mv	10.1177/2047487320914115
publisher	SAGE Publications
college_str	Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id	facultyofmedicinehealthandlifesciences
hierarchy_top_title	Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id	facultyofmedicinehealthandlifesciences
hierarchy_parent_title	Faculty of Medicine, Health and Life Sciences
department_str	Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str	1
active_str	0
description	European Society of Cardiology/European Atherosclerosis Society 2019 guidelines recommend more aggressive lipid targets in high- and very high-risk patients and the addition of adjuvant treatments to statins in uncontrolled patients. We aimed to assess (a) achievement of prior and new European Society of Cardiology/European Atherosclerosis Society lipid targets and (b) lipid-lowering therapy prescribing in a nationwide cohort of very high-risk patients.
published_date	2020-03-31T19:53:11Z
_version_	1821345884442460160
score	11.04748

Achievement of European guideline-recommended lipid levels post-percutaneous coronary intervention: A population-level observational cohort study

Similar Items